The Blue Cross and Blue Shield names and symbols are registered marks of the Blue Cross and Blue Shield Association
Retatrutide activates three hormone receptors at once: GLP-1R (reduces appetite, stimulates insulin), GIPR (boosts insulin and modulates appetite via a separate brain pathway), and GCGR (increases calorie burning and fat breakdown)
Only 8% of participants experienced minimal response (under 5% loss)
By understanding the causes, prevention, and treatment options, users can take proactive steps to manage this side effect
Because this is a small-molecule salt rather than a peptide, the usual peptide precautions about mechanical shear and methionine or tryptophan oxidation do not apply
In the SELECT trial (among others), it showed lower rates of major adverse cardiovascular events (such as heart attacks and strokes) compared to placebo, especially in overweight or obese patients